LASSA FEVER MITIGATION: COMBATTING AN EMERGING INFECTIOUS DISEASE THREAT

Abdullahi Ebenezer; Samuel Adesewa

doi:10.55640/gjmps-abcd05

Open Access

LASSA FEVER MITIGATION: COMBATTING AN EMERGING INFECTIOUS DISEASE THREAT

https://doi.org/10.55640/gjmps-abcd05

PDF

Abdullahi Ebenezer ¹ , Samuel Adesewa ¹ ,

⁴ Department of Chemistry, University of Ilorin, Ilorin, Nigeria

⁴ Department of Biochemistry, Adekunle Ajasin University, Nigeria

Abstract

Lassa fever, caused by the Lassa virus, is a severe viral hemorrhagic fever with significant public health implications in West Africa. The disease poses a substantial burden on affected communities, leading to high morbidity and mortality rates. As an emerging infectious disease threat, Lassa fever presents challenges in terms of prevention, diagnosis, and control. This paper explores strategies for mitigating the risk of Lassa fever transmission and outbreak escalation. Key components of Lassa fever mitigation efforts include public health education, community engagement, surveillance and early detection, vector control measures, healthcare worker protection, and vaccine development. By implementing multidimensional approaches that address both environmental and behavioral factors, stakeholders can enhance preparedness and response capabilities to combat the spread of Lassa fever and minimize its impact on public health.

Keywords

Lassa fever, Lassa virus, Hemorrhagic fever

References

📄 Mahdy MS, Chiang W, McLaughlin B, Derksen K (1989) Truxton BH, Neg K. Lassa fever: the first confirmed case imported into Canada. Can Dis Wkly Rep 15: 193-198.

📄 Ufberg JW, Karras DJ (2005) Update on emerging infections: news from the Centers for Disease Control and Prevention Imported Lassa fever. Ann Emerg Med 45: 323-326.

📄 Amorosa V, MacNeil A, McConnell R, Patel A, Dillon KE, et al. (2010) Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis 16:1598-600.

📄 Hugonnet S, Sax H, Pittet D (2002) Management of viral hemorrhagic

📄 fevers in Switzerland. Euro Surveill 7: 42-44.

📄 Haas WH, Breuer T, Pfaff G, Schmitz H, Kohler P, et al. (2003) Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 36: 1254-1258.

📄 Kitching A, Addiman S, Cathcart S, Bishop L, Krahé D, et al. (2009) A fatal case of Lassa fever in London, January 2009. Euro Surveill 14: 10-12.

📄 Hirabayashi Y, Oka S, Goto H, Shimada K, Kurata T, et al. (1989) The first imported case of Lassa fever in Japan. Nihon Rinsho 47: 71-75.

📄 Shimizu H (1989) Current status of imported infectious diseases and control policy of the Ministry of Health and Welfare. Nihon Rinsho 47:11-15.

📄 European Federation of Audiology Societies (EFAS) (2011) Infections and acquired hearing loss in Africa. Journal of Hearing Science 1: 32-34.

📄 Rojek JM, Kunz S (2008) Cell entry by human pathogenic arenaviruses. Cell Microbiol 10: 828-835.

📄 Buchmeier MJ, de la Torre JC, Peters CJ (2007) Arenaviridae: The viruses and their replication. Fields Virology 5: 1791-1827.

📄 Frame JD, Baldwin JMJ, Gocke DJ, Troup JM (1970) Lassa fever, a new virus disease of man from West Africa: Clinical description and pathological findings. Am J Trop Med Hyg 19: 670-676.

How to Cite

Abdullahi Ebenezer, & Samuel Adesewa. (2023). LASSA FEVER MITIGATION: COMBATTING AN EMERGING INFECTIOUS DISEASE THREAT. Global Journal of Medical and Pharmaceutical Sciences, 2(04), 01-07. https://doi.org/10.55640/gjmps-abcd05